1-4 of 4
Jeffrey T. Malik, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Host Genetic Background and Risk of Richter Syndrome: The Genotype of LRP4 Is An Independent Predictor of Chronic Lymphocytic Leukemia Transformation to Aggressive Lymphoma.

Davide Rossi, MD, Silvia Rasi, PhD, Claudio Tripodo, MD, Francesco Forconi, MD, PhD, Luca Laurenti, MD, Alessio Bruscaggin, PhD, Marco Fangazio, MD, Alessia Puma, MD, Elisa Sozzi, BSci, Jeffrey T. Malik, MD, Josep F. Nomdedeu, MD, Roberto Marasca, MD, Valter Gattei, MD, Ken H. Young, MD, PhD, Stefano A. Pileri, MD, Francesco Lauria, MD, Fabio Malavasi, MD, PhD, Silvia Deaglio, MD, PhD, Gianluca Gaidano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2340.
https://doi.org/10.1182/blood.V114.22.2340.2340
Published: 2009
Journal Articles

TP53 Mutations, the Most Frequent Genetic Lesion in Richter Syndrome, Represent An Independent Predictor of Survival Post Transformation.

Davide Rossi, MD, Valeria Spina, PhD, Clara Deambrogi, PhD, Marco Lucioni, MD, Luca Arcaini, MD, Gabrielle B. Rocque, MD, Jeffrey T. Malik, MD, Julie E. Chang, MD, Ekaterina Chigrinova, MD, Josep F. Nomdedeu, MD, Francesco Forconi, MD, PhD, Roberto Marasca, MD, Caroline Besson, MD, Vincenzo Canzonieri, MD, Marco Paulli, MD, Valter Gattei, MD, Francesco Bertoni, MD, Ken H. Young, MD, PhD, Gianluca Gaidano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 670.
https://doi.org/10.1182/blood.V114.22.670.670
Published: 2009
Journal Articles

Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study.

Ken H. Young, MD, PhD, Nancy Patten, PhD, Sim Truong, PhD, Jens Eickhoff, PhD, Gabrielle L. Rocque, MD, Jeffrey T. Malik, MD, Yan Li, PhD, Kazunori Kanehira, MD, PhD, Matthew Twohig, MD, William M. Rehrauer, PhD, Michelle A. Waknitz, MS, Brad S. Kahl, MD, Michael B. Moller, MD, PhD, Alexander Tzankov, PhD, Santiago M. Moreno, MD, Miguel A. Piris, MD, Carlo Visco, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Jeff C. Chang, MD, PhD, Govind Bhagat, MD, Jane N. Winter, MD, Huan-You Wang, MD, PhD, Cherie Dunphy, MD, Stacey O'Neill, MD, PhD, Eric D. Hsi, MD, Xianfeng Zhao, MD, PhD, Kristin Hunt, MD, Weina Chen, MD, PhD, Ronald S. Go, MD, William W.L. Choi, MD, Fan Zhou, MD, PhD, Magdalena Czader, MD, PhD, Yong Li, PhD, Suzanne Selvaggi, MD, James S. Malter, MD, Lin Wu, PhD
Journal: Blood
Blood (2009) 114 (22): 967.
https://doi.org/10.1182/blood.V114.22.967.967
Published: 2009
Journal Articles

Poor Survival Predicted by MDM2 Oncoprotein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Wild-Type TP53 Gene

Gabrielle L. Rocque, MD, Michael B. Møller, MD, Gisele W. B. Colleoni, MD, Margarita Sánchez-Beato, PhD, Tina M. Green, MD, Trine Thorborg, MD, Miguel A. Piris, MD, Jens C. Eickhoff, PhD, Matthew Twohig, MD, Jeffrey T. Malik, MD, Allen H. Young, Terry D. Oberley, MD, James S. Malter, MD, Judith Ferry, MD, Wing C. Chan, MD, Dennis D. Weisenburger, MD, Timothy C. Greiner, MD, Ken H. Young, MD
Journal: Blood
Blood (2008) 112 (11): 5269.
https://doi.org/10.1182/blood.V112.11.5269.5269
Published: 2008